21629741|t|Melatonin in mitochondrial dysfunction and related disorders.
21629741|a|Mitochondrial dysfunction is considered one of the major causative factors in the aging process, ischemia/reperfusion (I/R), septic shock, and neurodegenerative disorders like Parkinson's disease (PD), Alzheimer's disease (AD), and Huntington's disease (HD). Increased free radical generation, enhanced mitochondrial inducible nitric oxide (NO) synthase activity, enhanced NO production, decreased respiratory complex activity, impaired electron transport system, and opening of mitochondrial permeability transition pore all have been suggested as factors responsible for impaired mitochondrial function. Melatonin, the major hormone of the pineal gland, also acts as an antioxidant and as a regulator of mitochondrial bioenergetic function. Both in vitro and in vivo, melatonin was effective for preventing oxidative stress/nitrosative stress-induced mitochondrial dysfunction seen in experimental models of PD, AD, and HD. In addition, melatonin is known to retard aging and to inhibit the lethal effects of septic shock or I/R lesions by maintaining respiratory complex activities, electron transport chain, and ATP production in mitochondria. Melatonin is selectively taken up by mitochondrial membranes, a function not shared by other antioxidants. Melatonin has thus emerged as a major potential therapeutic tool for treating neurodegenerative disorders such as PD or AD, and for preventing the lethal effects of septic shock or I/R.
21629741	0	9	Melatonin	Chemical	MESH:D008550
21629741	13	38	mitochondrial dysfunction	Disease	MESH:D028361
21629741	62	87	Mitochondrial dysfunction	Disease	MESH:D028361
21629741	159	167	ischemia	Disease	MESH:D007511
21629741	187	199	septic shock	Disease	MESH:D012772
21629741	205	232	neurodegenerative disorders	Disease	MESH:D019636
21629741	238	257	Parkinson's disease	Disease	MESH:D010300
21629741	259	261	PD	Disease	MESH:D010300
21629741	264	283	Alzheimer's disease	Disease	MESH:D000544
21629741	285	287	AD	Disease	MESH:D000544
21629741	294	314	Huntington's disease	Disease	MESH:D006816
21629741	316	318	HD	Disease	MESH:D006816
21629741	635	666	impaired mitochondrial function	Disease	MESH:D028361
21629741	668	677	Melatonin	Chemical	MESH:D008550
21629741	832	841	melatonin	Chemical	MESH:D008550
21629741	915	940	mitochondrial dysfunction	Disease	MESH:D028361
21629741	972	974	PD	Disease	MESH:D010300
21629741	976	978	AD	Disease	MESH:D000544
21629741	984	986	HD	Disease	MESH:D006816
21629741	1001	1010	melatonin	Chemical	MESH:D008550
21629741	1073	1085	septic shock	Disease	MESH:D012772
21629741	1089	1100	I/R lesions	Disease	MESH:D015427
21629741	1178	1181	ATP	Chemical	MESH:D000255
21629741	1210	1219	Melatonin	Chemical	MESH:D008550
21629741	1317	1326	Melatonin	Chemical	MESH:D008550
21629741	1395	1422	neurodegenerative disorders	Disease	MESH:D019636
21629741	1431	1433	PD	Disease	MESH:D010300
21629741	1437	1439	AD	Disease	MESH:D000544
21629741	1482	1494	septic shock	Disease	MESH:D012772
21629741	Negative_Correlation	MESH:D008550	MESH:D019636
21629741	Negative_Correlation	MESH:D008550	MESH:D010300
21629741	Association	MESH:D000255	MESH:D015427
21629741	Negative_Correlation	MESH:D008550	MESH:D015427
21629741	Negative_Correlation	MESH:D008550	MESH:D006816
21629741	Negative_Correlation	MESH:D008550	MESH:D012772
21629741	Negative_Correlation	MESH:D008550	MESH:D028361
21629741	Negative_Correlation	MESH:D008550	MESH:D000544
21629741	Positive_Correlation	MESH:D000255	MESH:D008550

